Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 80, Issue 1, 2003, Pages 86-90

  Chen, Chin Der ^a   Chao, Kuang Han ^a   Yang, Jehn Hsiahn ^a   Chen, Shee Uan ^a   Ho, Hong Nerng ^a   Yang, Yu Shih ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Albumin; Coasting; IVF outcome; Ovarian hyperstimulation syndrome

Indexed keywords

ALBUMIN; GONADOTROPIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMBRYO; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; NIDATION; OOCYTE; OVARY DISEASE; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

EID: 0038045257     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00548-X     Document Type: Article

References (23)

1. Delvigne A., Rozenberg S. Preventive attitude of physicians to avoid OHSS in IVF patients. Hum Reprod. 16:2001;2491-2495.
2. Urman B., Pride S.M., Yuen B.H. Management of overstimulated gonadotrophin cycles with a controlled drift period. Hum Reprod. 7:1992;213-217.
3. Chen C.D., Wu M.Y., Yang J.H., Chen S.U., Ho H.N., Yang Y.S. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. Fertil Steril. 68:1997;287-291.
4. Benadiva C.A., Davis O., Kligman I., Moomjy M., Liu H.C., Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril. 67:1997;724-727.
5. Tortoriello D.V., McGovern P.G., Colon J.M., Skurnick J.H., Lipetz K., Santoro N. "Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steril. 69:1998;454-460.
6. Fluker M.R., Hooper W.M., Yuzpe A.A. Withholding gonadotropins ("coasting") to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fertil Steril. 71:1999;294-301.
7. Chen C.D., Wu M.Y., Chen H.F., Chen S.U., Ho H.N., Yang Y.S. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil Steril. 72:1999;286-292.
8. Golan A., Ron-el R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome an update review . Obstet Gynecol Surv. 44:1989;430-440.
9. Fleming R., Rehka P., Deshpande N., Jamieson M.E., Yates R.W., Lyall H. Suppression of LH during ovarian stimulation effects differ in cycles stimulated with purified urinary FSH and recombinant FSH . Hum Reprod. 15:2000;1440-1445.
10. Fluker M.R., Marshall L.A., Monroe S.E., Jaffe R.B. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle. J Clin Endocrinol Metab. 72:1991;912-919.
11. Sher G., Zouves C., Feinman M., Maassarani G. "Prolonged coasting:" an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization . Hum Reprod. 10:1995;3107-3109.
12. Sirard M.A., Picard L., Dery M., Coenen K., Blondin P. The time interval between FSH administration and ovarian aspiration influences the development of cattle oocytes. Theriogenology. 51:1999;699-708.
13. Blondin P., Sirard M.A. Oocyte and follicular morphology as determining characteristics for developmental competence in bovine oocytes. Mol Reprod Dev. 41:1995;54-62.
14. Salamone D.F., Adams G.P., Mapletoft R.J. Changes in the cumulus-oocyte complex of subordinate follicles relative to follicular wave status in cattle. Theriogenology. 52:1999;549-561.
15. Blondin P., Guilbault L.A., Sirard M.-A. The time interval between FSH-P administration and slaughter can influence the developmental competence of beef heifer oocytes. Theriogenology. 48:1997;803-813.
16. Lee C., Tummon I., Martin J., Nisker J., Power S., Tekpetey F. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome? Hum Reprod. 13:1998;1157-1158.
17. Sher G., Salem R., Feinman M., Dodge S., Zouves C., Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents a report on women undergoing in vitro fertilization and embryo transfer . Obstet Gynecol. 81:1993;1009-1011.
18. Dhont M., Van der S.F., De Sutter P. Prevention of severe ovarian hyperstimulation by coasting. Fertil Steril. 70:1998;847-850.
19. Ulug U., Bahceci M., Erden H.F., Shalev E., Ben-Shlomo I. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod. 17:2002;310-313.
20. Cahill D.J., Wardle P.G., Harlow C.R., Hull M.G. Onset of the preovulatory luteinizing hormone surge diurnal timing and critical follicular prerequisites . Fertil Steril. 70:1998;56-59.
21. Whelan J.G. III, Vlahos N.F. The ovarian hyperstimulation syndrome. Fertil Steril. 73:2000;883-896.
22. Egbase P.E., Al Sharhan M., Grudzinskas J.G. "Early coasting" in patients with polycystic ovarian syndrome is consistent with good clinical outcome. Hum Reprod. 17:2002;1212-1216.
23. Aboulghar M.A., Mansour R.T., Serour G.I., Rhodes C.A., Amin Y.M. Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation. J Assist Reprod Genet. 17:2000;298-301.